Evidence map›Paper›PMID 12618555›Full record

ReviewReviews in endocrine & metabolic disorders2003

Developmental aspects of the endocrine pancreas.

Daniel M Kemp, Melissa K Thomas, Joel F Habener

Abstract readReview
PubMed Publisher
In one paragraph

Review in Reviews in endocrine & metabolic disorders, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Development of the endocrine pancreas.Reviews in endocrine & metabolic disorders · 2005
    Review
  7. Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  8. Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development.Proceedings of the National Academy of Sciences of the United States of America · 2004
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daniel M KempLaboratory of Molecular Endocrinology, Massachusetts General Hospital, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02114, USA.
Melissa K Thomas
Joel F Habener

Funding

TRANSCRIPTION FACTORS AND THE ENDOCRINE PANCREASR01DK055365 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI HABENER, JOEL F · 1999 to 2003
$1.0M
REGULATION OF INSULIN GENE TRANSCRIPTION IN DIABETESK08DK002476 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI THOMAS, MELISSA K · 1997 to 2001
$249k
NIDDK NIH HHS DK02476NIDDK NIH HHS DK55365
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCell DifferentiationCell LineageHumansIslets of LangerhansPancreasSignal Transduction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.